Teva Pharmaceutical Industries has announced the launch of the generic equivalent of Lomedia 24 Fe (norethindrone acetate and ethinyl estradiol tablets USP, 1 mg/20 mcg and ferrous fumarate tablets, 75 mg) as part of the extensive line of Women’s Health products. The product will be launched under the name Junel Fe 24 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets) and is now available in the United States.
Teva recognizes that women’s needs change over time and the portfolio of Women’s Health products is positioned to support women through many stages of life. With the addition of Junel Fe 24, Teva can offer women a comprehensive line of nearly 30 generic contraceptive products.
Lomedia 24 Fe marketed by Amneal had annual sales of approximately $32 million in the US, according to IMS data as of December 2014.
